Context- and Tissue-Specific Regulation of Immunity and Tolerance by Regulatory T Cells

Advances in Immunology

Volumn 132, Issue , 2016, Pages 1-46

  Ulges, A ^a   Schmitt, E ^a   Becker, C ^a   Bopp, T ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

FOXP3; Regulation; Regulatory T cell; Suppression; Thymus; Tissue

Indexed keywords

CELL MATURATION; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INTESTINE CELL; INTRAPERITONEAL FAT; LUNG ALVEOLUS CELL; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; METABOLIC DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKELETAL MUSCLE CELL; SKIN CELL; ANIMAL; ANTIBODY SPECIFICITY; IMMUNITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

AUTOANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ANIMALS; AUTOANTIGENS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNITY; IMMUNOSUPPRESSION; ORGAN SPECIFICITY; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84999663732     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2016.08.002     Document Type: Chapter

References (241)

1. Abbas, A.K., Benoist, C., Bluestone, J.A., Campbell, D.J., Ghosh, S., Hori, S., et al. Regulatory T cells: Recommendations to simplify the nomenclature. Nature Immunology 14:4 (2013), 307–308 http://doi.org/10.1038/ni.2554.
2. Ait-Oufella, H., Salomon, B.L., Potteaux, S., Robertson, A.-K.L., Gourdy, P., Zoll, J., et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nature Medicine 12:2 (2006), 178–180 http://doi.org/10.1038/nm1343.
3. Anderson, C.F., Oukka, M., Kuchroo, V.J., Sacks, D., CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. Journal of Experimental Medicine 204:2 (2007), 285–297 http://doi.org/10.1084/jem.20061886.
4. Annacker, O., Asseman, C., Read, S., Powrie, F., Interleukin-10 in the regulation of T cell-induced colitis. Journal of Autoimmunity 20:4 (2003), 277–279 http://doi.org/10.1016/S0896-8411(03)00045-3.
5. Apostolou, I., Sarukhan, A., Klein, L., von Boehmer, H., Origin of regulatory T cells with known specificity for antigen. Nature Immunology 3:8 (2002), 756–763.
6. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. Journal of Experimental Medicine 204:5 (2007), 1057–1069 http://doi.org/10.1084/jem.20070075.
7. Arpaia, N., Green, J.A., Moltedo, B., Arvey, A., Hemmers, S., Yuan, S., et al. A distinct function of regulatory T cells in tissue protection. Cell 162:5 (2015), 1078–1089 http://doi.org/10.1016/j.cell.2015.08.021.
8. Asano, M., Toda, M., Sakaguchi, N., Sakaguchi, S., Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. Journal of Experimental Medicine 184:2 (1996), 387–396.
9. Aschenbrenner, K., D'Cruz, L.M., Vollmann, E.H., Hinterberger, M., Emmerich, J., Swee, L.K., et al. Selection of Foxp3 + regulatory T cells specific for self antigen expressed and presented by Aire + medullary thymic epithelial cells. Nature Immunology 8:4 (2007), 351–358 http://doi.org/10.1038/ni1444.
10. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L., Powrie, F., An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. Journal of Experimental Medicine 190:7 (1999), 995–1004 http://doi.org/10.1084/jem.190.7.995.
11. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 331:6015 (2011), 337–341 http://doi.org/10.1126/science.1198469.
12. Azukizawa, H., Döhler, A., Kanazawa, N., Nayak, A., Lipp, M., Malissen, B., et al. Steady state migratory RelB + langerin + dermal dendritic cells mediate peripheral induction of antigen-specific CD4+CD25+Foxp3 + regulatory T cells. European Journal of Immunology 41:5 (2011), 1420–1434 http://doi.org/10.1002/eji.201040930.
13. Baecher-Allan, C., Wolf, E., Hafler, D.A., MHC class II expression identifies functionally distinct human regulatory T cells. Journal of Immunology 176:8 (2006), 4622–4631 http://doi.org/10.4049/jimmunol.176.8.4622.
14. Bai, A., Hu, H., Yeung, M., Chen, J., Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. Journal of Immunology 178:12 (2007), 7632–7639 http://doi.org/10.4049/jimmunol.178.12.7632.
15. Banham, A.H., Powrie, F.M., Suri-Payer, E., FOXP3 + regulatory T cells: Current controversies and future perspectives. European Journal of Immunology 36:11 (2006), 2832–2836 http://doi.org/10.1002/eji.200636459.
16. Bankovich, A.J., Shiow, L.R., Cyster, J.G., CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. The Journal of Biological Chemistry 285:29 (2010), 22328–22337 http://doi.org/10.1074/jbc.M110.123299.
17. Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grützkau, A., Dong, J., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3 + conventional T cells. European Journal of Immunology 37:9 (2007), 2378–2389 http://doi.org/10.1002/eji.200737594.
18. Battaglia, M., Roncarolo, M.G., The Tregs’ world according to GARP. European Journal of Immunology 39:12 (2009), 3296–3300 http://doi.org/10.1002/eji.200940117.
19. Beiting, D.P., Gagliardo, L.F., Hesse, M., Bliss, S.K., Meskill, D., Appleton, J.A., Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-beta. Journal of Immunology 178:2 (2007), 1039–1047 http://doi.org/10.4049/jimmunol.178.2.1039.
20. Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach, E.M., Sacks, D.L., CD4+CD25 + regulatory T cells control Leishmania major persistence and immunity. Nature 420:6915 (2002), 502–507.
21. Belkaid, Y., Tamoutounour, S., The influence of skin microorganisms on cutaneous immunity. Nature Reviews. Immunology 16:6 (2016), 353–366 http://doi.org/10.1038/nri.2016.48.
22. Beltrán, C.J., Núñez, L.E., Díaz-Jiménez, D., Farfan, N., Candia, E., Heine, C., et al. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 16:7 (2010), 1097–1107 http://doi.org/10.1002/ibd.21175.
23. Bergmann, C., Strauss, L., Zeidler, R., Lang, S., Whiteside, T.L., Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment. Cancer Immunology, Immunotherapy 56:9 (2007), 1429–1442 http://doi.org/10.1007/s00262-007-0280-9.
24. Boehm, T., Bleul, C.C., The evolutionary history of lymphoid organs. Nature Immunology 8:2 (2007), 131–135 http://doi.org/10.1038/ni1435.
25. Bopp, T., Becker, C., Klein, M., Klein-Hessling, S., Palmetshofer, A., Serfling, E., et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. The Journal of Experimental Medicine 204:6 (2007), 1303–1310 http://doi.org/10.1084/jem.20062129.
26. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., et al. Expression of ectonucleotidase CD39 by Foxp3 + Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110:4 (2007), 1225–1232 http://doi.org/10.1182/blood-2006-12-064527.
27. Bosello, O., Zamboni, M., Visceral obesity and metabolic syndrome. Obesity Reviews 1:1 (2000), 47–56 http://doi.org/10.1046/j.1467-789x.2000.00008.x.
28. + Treg compared to Foxp3—Conventional T cells to TCR-independent signals for CD69 induction. PLoS One, 10(9), 2015, e0137393 http://doi.org/10.1371/journal.pone.0137393.
29. Burocchi, A., Colombo, M.P., Piconese, S., Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancer. Frontiers in Immunology, 4, 2013, 247 http://doi.org/10.3389/fimmu.2013.00247.
30. Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J.L., Cerletti, M., Jang, Y., et al. A special populationof regulatory T cells potentiates muscle repair. Cell 155:6 (2013), 1282–1295 http://doi.org/10.1016/j.cell.2013.10.054.
31. Busse, D., de la Rosa, M., Hobiger, K., Thurley, K., Flossdorf, M., Scheffold, A., et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proceedings of the National Academy of Sciences of the United States of America 107:7 (2010), 3058–3063 http://doi.org/10.1073/pnas.0812851107.
32. Cao, X., Cai, S.F., Fehniger, T.A., Song, J., Collins, L.I., Piwnica-Worms, D.R., et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27:4 (2007), 635–646 http://doi.org/10.1016/j.immuni.2007.08.014.
33. Carlson, C.M., Endrizzi, B.T., Wu, J., Ding, X., Weinreich, M.A., Walsh, E.R., et al. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442:7100 (2006), 299–302 http://doi.org/10.1038/nature04882.
34. Carretero, R., Sektioglu, I.M., Garbi, N., Salgado, O.C., Beckhove, P., Hämmerling, G.J., Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8 + T cells. Nature Immunology 16:6 (2015), 609–617 http://doi.org/10.1038/ni.3159.
35. Chan-Wang Joaquim Lio, C.-S.H., A two-step process for thymic regulatory T cell development. Immunity 28:1 (2008), 100–111 http://doi.org/10.1016/j.immuni.2007.11.021.
36. Chaudhry, A., Rudra, D., Treuting, P., Samstein, R.M., Liang, Y., Kas, A., et al. CD4 + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326:5955 (2009), 986–991 http://doi.org/10.1126/science.1172702.
37. Chaudhry, A., Samstein, R.M., Treuting, P., Liang, Y., Pils, M.C., Heinrich, J.-M., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34:4 (2011), 566–578 http://doi.org/10.1016/j.immuni.2011.03.018.
38. Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S.E., et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486:7404 (2012), 549–553 http://doi.org/10.1038/nature11132.
39. Clark, R.A., Kupper, T.S., IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood 109:1 (2007), 194–202 http://doi.org/10.1182/blood-2006-02-002873.
40. Coleman, M.M., Ruane, D., Moran, B., Dunne, P.J., Keane, J., Mills, K.H.G., Alveolar macrophages contribute to respiratory tolerance by inducing FoxP3 expression in naive T cells. American Journal of Respiratory Cell and Molecular Biology 48:6 (2013), 773–780 http://doi.org/10.1165/rcmb.2012-0263OC.
41. Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:7169 (2007), 566–569 http://doi.org/10.1038/nature06306.
42. Conlon, M., Bird, A., The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7:1 (2015), 17–44 http://doi.org/10.3390/nu7010017.
43. Cowan, J.E., McCarthy, N.I., Anderson, G., CCR7 controls thymus recirculation, but not production and emigration, of Foxp3 + T cells. Cell Reports 14:5 (2016), 1041–1048 http://doi.org/10.1016/j.celrep.2016.01.003.
44. Davies, L.C., Jenkins, S.J., Allen, J.E., Taylor, P.R., Tissue-resident macrophages. Nature Immunology 14:10 (2013), 986–995 http://doi.org/10.1038/ni.2705.
45. de la Rosa, M., Rutz, S., Dorninger, H., Scheffold, A., Interleukin-2 is essential for CD4+CD25 + regulatory T cell function. European Journal of Immunology 34:9 (2004), 2480–2488 http://doi.org/10.1002/eji.200425274.
46. Deaglio, S., Dwyer, K.M., Gao, W., Friedman, D., Usheva, A., Erat, A., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. The Journal of Experimental Medicine 204:6 (2007), 1257–1265.
47. Deiuliis, J., Shah, Z., Shah, N., Needleman, B., Mikami, D., Narula, V., et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One, 6(1), 2011, e16376 http://doi.org/10.1371/journal.pone.0016376.
48. Derbinski, J., Gäbler, J., Brors, B., Tierling, S., Jonnakuty, S., Hergenhahn, M., et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. Journal of Experimental Medicine 202:1 (2005), 33–45 http://doi.org/10.1084/jem.20050471.
49. Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., Schuler, G., Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. Journal of Experimental Medicine 193:11 (2001), 1303–1310.
50. Droeser, R., Zlobec, I., Kilic, E., Güth, U., Heberer, M., Spagnoli, G., et al. Differential pattern and prognostic significance of CD4 +, FOXP3 + and IL-17 + tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC Cancer, 12(1), 2012, 1 http://doi.org/10.1186/1471-2407-12-134.
51. Duhen, T., Duhen, R., Lanzavecchia, A., Sallusto, F., Campbell, D.J., Functionally distinct subsets of human FOXP3 + Treg cells that phenotypically mirror effector Th cells. Blood 119:19 (2012), 4430–4440 http://doi.org/10.1182/blood-2011-11-392324.
52. Duthoit, C.T., Mekala, D.J., Alli, R.S., Geiger, T.L., Uncoupling of IL-2 signaling from cell cycle progression in naive CD4 + T cells by regulatory CD4+CD25 + T lymphocytes. Journal of Immunology 174:1 (2005), 155–163 http://doi.org/10.4049/jimmunol.174.1.155.
53. Eksteen, B., Miles, A., Curbishley, S.M., Tselepis, C., Grant, A.J., Walker, L.S.K., et al. Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10. Journal of Immunology 177:1 (2006), 593–603 http://doi.org/10.4049/jimmunol.177.1.593.
54. Eller, K., Kirsch, A., Wolf, A.M., Sopper, S., Tagwerker, A., Stanzl, U., et al. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 60:11 (2011), 2954–2962 http://doi.org/10.2337/db11-0358.
55. Erdman, S.E., Poutahidis, T., Cancer inflammation and regulatory T cells. International Journal of Cancer 127:4 (2010), 768–779 http://doi.org/10.1002/ijc.25430.
56. Fahlen, L., Read, S., Gorelik, L., Hurst, S.D., Coffman, R.L., Flavell, R.A., et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. The Journal of Experimental Medicine 201:5 (2005), 737–746.
57. Fallarino, F., Grohmann, U., Hwang, K.W., Orabona, C., Vacca, C., Bianchi, R., et al. Modulation of tryptophan catabolism by regulatory T cells. Nature Immunology 4:12 (2003), 1206–1212 http://doi.org/10.1038/ni1003.
58. Fassbender, M., Gerlitzki, B., Ullrich, N., Lupp, C., Klein, M., Radsak, M.P., et al. Cyclic adenosine monophosphate and IL-10 coordinately contribute to nTreg cell-mediated suppression of dendritic cell activation. Cellular Immunology 265:2 (2010), 91–96 http://doi.org/10.1016/j.cellimm.2010.07.007.
59. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 15 (2009), 930–939 http://doi.org/10.1038/nm.2002.
60. Flajnik, M.F., Kasahara, M., Origin and evolution of the adaptive immune system: Genetic events and selective pressures. Nature Reviews. Genetics 11:1 (2010), 47–59 http://doi.org/10.1038/nrg2703.
61. Fontenot, J.D., Dooley, J.L., Farr, A.G., Rudensky, A.Y., Developmental regulation of Foxp3 expression during ontogeny. The Journal of Experimental Medicine 202:7 (2005), 901–906.
62. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A., Rudensky, A.Y., A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunology 6:11 (2005), 1142–1151.
63. Frey, D.M., Droeser, R.A., Viehl, C.T., Zlobec, I., Lugli, A., Zingg, U., et al. High frequency of tumor-infiltrating FOXP3 + regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. International Journal of Cancer 126:11 (2010), 2635–2643 http://doi.org/10.1002/ijc.24989.
64. Friedline, R.H., Brown, D.S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., et al. CD4 + regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. The Journal of Experimental Medicine 206:2 (2009), 421–434 http://doi.org/10.1084/jem.20081811.
65. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T.A., Nakato, G., Takahashi, D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450 http://doi.org/10.1038/nature12721.
66. Gao, Y., Nish, S.A., Jiang, R., Hou, L., Licona Limon, P., Weinstein, J.S., et al. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 39:4 (2013), 722–732 http://doi.org/10.1016/j.immuni.2013.08.028.
67. Geuking, M.B., Cahenzli, J., Lawson, M.A.E., Ng, D.C.K., Slack, E., Hapfelmeier, S., et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 34:5 (2011), 794–806 http://doi.org/10.1016/j.immuni.2011.03.021.
68. Godfrey, V.L., Wilkinson, J.E., Russell, L.B., X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. The American Journal of Pathology 138:6 (1991), 1379–1387.
69. Gollwitzer, E.S., Saglani, S., Trompette, A., Yadava, K., Sherburn, R., McCoy, K.D., et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nature Medicine 20:6 (2014), 642–647 http://doi.org/10.1038/nm.3568.
70. Gondek, D.C., DeVries, V., Nowak, E.C., Lu, L.-F., Bennett, K.A., Scott, Z.A., et al. Transplantation survival is maintained by granzyme B + regulatory cells and adaptive regulatory T cells. Journal of Immunology (Baltimore, Md.: 1950) 181:7 (2008), 4752–4760 http://doi.org/10.4049/jimmunol.181.7.4752.
71. Gondek, D.C., Lu, L.F., Quezada, S.A., Sakaguchi, S., Noelle, R.J., Cutting edge: Contact-mediated suppression by CD4+CD25 + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. Journal of Immunology (Baltimore, Md.: 1950) 174:4 (2005), 1783–1786.
72. Graca, L., Cobbold, S.P., Waldmann, H., Identification of regulatory T cells in tolerated allografts. Journal of Experimental Medicine 195:12 (2002), 1641–1646 http://doi.org/10.1084/jem.20012097.
73. Graham, J.B., Da Costa, A., Lund, J.M., Regulatory T cells shape the resident memory T cell response to virus infection in the tissues. Journal of Immunology (Baltimore, Md.: 1950) 192:2 (2014), 683–690 http://doi.org/10.4049/jimmunol.1202153.
74. Green, E.A., Gorelik, L., McGregor, C.M., Tran, E.H., Flavell, R.A., CD4+CD25 + T regulatory cells control anti-islet CD8 + T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proceedings of the National Academy of Sciences of the United States of America 100:19 (2003), 10878–10883 http://doi.org/10.1073/pnas.1834400100.
75. Grice, E.A., Segre, J.A., The skin microbiome. Nature Reviews. Microbiology 9:4 (2011), 244–253 http://doi.org/10.1038/nrmicro2537.
76. Griseri, T., Asquith, M., Thompson, C., Powrie, F., OX40 is required for regulatory T cell-mediated control of colitis. The Journal of Experimental Medicine 207:4 (2010), 699–709 http://doi.org/10.1084/jem.20091618.
77. Grossman, W.J., Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104:9 (2004), 2840–2848 http://doi.org/10.1182/blood-2004-03-0859.
78. Guilliams, M., Crozat, K., Henri, S., Tamoutounour, S., Grenot, P., Devilard, E., et al. Skin-draining lymph nodes contain dermis-derived CD103 − dendritic cells that constitutively produce retinoic acid and induce Foxp3 + regulatory T cells. Blood 115:10 (2010), 1958–1968 http://doi.org/10.1182/blood-2009-09-245274.
79. Hale, J.S., Fink, P.J., Back to the thymus: Peripheral T cells come home. Immunology and Cell Biology 87:1 (2008), 58–64 http://doi.org/10.1038/icb.2008.87.
80. Hanabuchi, S., Ito, T., Park, W.-R., Watanabe, N., Shaw, J.L., Roman, E., et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3 + regulatory T cells in human thymus. Journal of Immunology (Baltimore, Md.: 1950) 184:6 (2010), 2999–3007 http://doi.org/10.4049/jimmunol.0804106.
81. Hayakawa, M., Yanagisawa, K., Aoki, S., Hayakawa, H., Takezako, N., Tominaga, S.-I., T-helper type 2 cell-specific expression of the ST2 gene is regulated by transcription factor GATA-3. Biochimica et Biophysica Acta 1728:1–2 (2005), 53–64 http://doi.org/10.1016/j.bbaexp.2005.01.012.
82. Henson, S.M., Riddell, N.E., Akbar, A.N., Properties of end-stage human T cells defined by CD45RA re-expression. Current Opinion in Immunology 24:4 (2012), 476–481 http://doi.org/10.1016/j.coi.2012.04.001.
83. Herman, A.E., Freeman, G.J., Mathis, D., Benoist, C., CD4+CD25 + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. Journal of Experimental Medicine 199:11 (2004), 1479–1489 http://doi.org/10.1084/jem.20040179.
84. Hilchey, S.P., De, A., Rimsza, L.M., Bankert, R.B., Bernstein, S.H., Follicular lymphoma intratumoral CD4+CD25+GITR + regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells. Journal of Immunology 178:7 (2007), 4051–4061.
85. Hinz, S., Pagerols-Raluy, L., Oberg, H.-H., Ammerpohl, O., Grüssel, S., Sipos, B., et al. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Research 67:17 (2007), 8344–8350 http://doi.org/10.1158/0008-5472.CAN-06-3304.
86. Honda, T., Miyachi, Y., Kabashima, K., Regulatory T cells in cutaneous immune responses. Journal of Dermatological Science 63:2 (2011), 75–82 http://doi.org/10.1016/j.jdermsci.2011.06.004.
87. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259:5091 (1993), 87–91 http://doi.org/10.1126/science.7678183.
88. Hsieh, C.-S., Lee, H.-M., Lio, C.-W.J., Selection of regulatory T cells in the thymus. Nature Reviews Immunology 12 (2012), 157–167 http://doi.org/10.1038/nri3155.
89. Huang, C.T., Workman, C.J., Flies, D., Pan, X., Marson, A.L., Zhou, G., et al. Role of LAG-3 in regulatory T cells. Immunity 21:4 (2004), 503–513.
90. − and Foxp3 + regulatory CD4 + T cells in an interleukin-10-dependent manner. Immunity 34:4 (2011), 554–565 http://doi.org/10.1016/j.immuni.2011.01.020.
91. Iellem, A., Colantonio, L., D'Ambrosio, D., Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25 + suppressor T cells. European Journal of Immunology 33:6 (2003), 1488–1496 http://doi.org/10.1002/eji.200323658.
92. Ilan, Y., Maron, R., Tukpah, A.-M., Maioli, T.U., Murugaiyan, G., Yang, K., et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proceedings of the National Academy of Sciences of the United States of America 107:21 (2010), 9765–9770 http://doi.org/10.1073/pnas.0908771107.
93. Ishimaru, N., Nitta, T., Arakaki, R., Yamada, A., Lipp, M., Takahama, Y., et al. In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy. PLoS One, 5(1), 2010, e8588 http://doi.org/10.1371/journal.pone.0008588.
94. Itoh, M., Takahashi, T., Sakaguchi, N., Kuniyasu, Y., Shimizu, J., Otsuka, F., et al. Thymus and autoimmunity: Production of CD25+CD4 + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. Journal of Immunology (Baltimore, Md.: 1950) 162:9 (1999), 5317–5326.
95. Iype, T., Sankarshanan, M., Mauldin, I.S., Mullins, D.W., Lorenz, U., The protein tyrosine phosphatase SHP-1 modulates the suppressive activity of regulatory T cells. Journal of Immunology (Baltimore, Md.: 1950) 185:10 (2010), 6115–6127 http://doi.org/10.4049/jimmunol.1000622.
96. Jankovic, D., Kullberg, M.C., Feng, C.G., Goldszmid, R.S., Collazo, C.M., Wilson, M., et al. Conventional T-bet+Foxp3 − Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. The Journal of Experimental Medicine 204:2 (2007), 273–283 http://doi.org/10.1084/jem.20062175.
97. Jie, H.-B., Gildener-Leapman, N., Li, J., Srivastava, R.M., Gibson, S.P., Whiteside, T.L., et al. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. British Journal of Cancer 109:10 (2013), 2629–2635 http://doi.org/10.1038/bjc.2013.645.
98. Joetham, A., Takeda, K., Taube, C., Miyahara, N., Matsubara, S., Koya, T., et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. Journal of Immunology (Baltimore, Md.: 1950) 178:3 (2007), 1433–1442.
99. Joller, N., Lozano, E., Burkett, P.R., Patel, B., Xiao, S., Zhu, C., et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40:4 (2014), 569–581 http://doi.org/10.1016/j.immuni.2014.02.012.
100. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., Enk, A.H., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. The Journal of Experimental Medicine 193:11 (2001), 1285–1294.
101. Jordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck, A.E., Lerman, M.A., et al. Thymic selection of CD4+CD25 + regulatory T cells induced by an agonist self-peptide. Nature Immunology 2:4 (2001), 301–306.
102. Josefowicz, S.Z., Lu, L.-F., Rudensky, A.Y., Regulatory T cells: Mechanisms of differentiation and function. Annual Review of Immunology 30 (2012), 531–564 http://doi.org/10.1146/annurev.immunol.25.022106.141623.
103. Josefowicz, S.Z., Niec, R.E., Kim, H.Y., Treuting, P., Chinen, T., Zheng, Y., et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482:7385 (2012), 395–399 http://doi.org/10.1038/nature10772.
104. Karanikas, V., Speletas, M., Zamanakou, M., Kalala, F., Loules, G., Kerenidi, T., et al. Foxp3 expression in human cancer cells. Journal of Translational Medicine, 6(1), 2008, 1 http://doi.org/10.1186/1479-5876-6-19.
105. Katz, S.C., Ryan, K., Ahmed, N., Plitas, G., Chaudhry, U.I., Kingham, T.P., et al. Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. Journal of Immunology (Baltimore, Md.: 1950) 187:3 (2011), 1150–1156 http://doi.org/10.4049/jimmunol.1004077.
106. Kearley, J., Robinson, D.S., Lloyd, C.M., CD4(+)CD25(+) regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. The Journal of Allergy and Clinical Immunology 122 (2008), 617–624.
107. Kim, K.S., Hong, S.-W., Han, D., Yi, J., Jung, J., Yang, B.-G., et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351 (2016), 858–863 aac5560 http://doi.org/10.1126/science.aac5560.
108. Kingsley, C.I., Karim, M., Bushell, A.R., Wood, K.J., CD25+CD4 + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. Journal of Immunology 168:3 (2002), 1080–1086 http://doi.org/10.4049/jimmunol.168.3.1080.
109. Klages, K., Mayer, C.T., Lahl, K., Loddenkemper, C., Teng, M.W.L., Ngiow, S.F., et al. Selective depletion of Foxp3 + regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Research 70:20 (2010), 7788–7799 http://doi.org/10.1158/0008-5472.CAN-10-1736.
110. Kleinewietfeld, M., Puentes, F., Borsellino, G., Battistini, L., Rötzschke, O., Falk, K., CCR6 expression defines regulatory effector/memory-like cells within the CD25(+)CD4 + T-cell subset. Blood 105:7 (2005), 2877–2886 http://doi.org/10.1182/blood-2004-07-2505.
111. Kleinewietfeld, M., Starke, M., Di Mitri, D., Borsellino, G., Battistini, L., Rotzschke, O., et al. CD49d provides access to “untouched” human Foxp3 + Treg free of contaminating effector cells. Blood 113:4 (2009), 827–836 http://doi.org/10.1182/blood-2008-04-150524.
112. Kleinschnitz, C., Kraft, P., Dreykluft, A., Hagedorn, I., Göbel, K., Schuhmann, M.K., et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 121:4 (2013), 679–691 http://doi.org/10.1182/blood-2012-04-426734.
113. Klingenberg, R., Gerdes, N., Badeau, R.M., Gisterå, A., Strodthoff, D., Ketelhuth, D.F.J., et al. Depletion of FOXP3 + regulatory T cells promotes hypercholesterolemia and atherosclerosis. The Journal of Clinical Investigation 123:3 (2013), 1323–1334 http://doi.org/10.1172/JCI63891.
114. Kobie, J.J., Shah, P.R., Yang, L., Rebhahn, J.A., Fowell, D.J., Mosmann, T.R., T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. Journal of Immunology (Baltimore, Md.: 1950) 177:10 (2006), 6780–6786.
115. Kobori, A., Yagi, Y., Imaeda, H., Ban, H., Bamba, S., Tsujikawa, T., et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. Journal of Gastroenterology 45:10 (2010), 999–1007 http://doi.org/10.1007/s00535-010-0245-1.
116. Koch, M.A., Tucker-Heard, G., Perdue, N.R., Killebrew, J.R., Urdahl, K.B., Campbell, D.J., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunology 10:6 (2009), 595–602 http://doi.org/10.1038/ni.1731.
117. Kolodin, D., van Panhuys, N., Li, C., Magnuson, A.M., Cipolletta, D., Miller, C.M., et al. Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice. Cell Metabolism 21:4 (2015), 543–557 http://doi.org/10.1016/j.cmet.2015.03.005.
118. Kumar, V., Kono, D.H., Urban, J.L., Hood, L., The T-cell receptor repertoire and autoimmune diseases. Annual Review of Immunology 7:1 (1989), 657–682 http://doi.org/10.1146/annurev.iy.07.040189.003301.
119. Kuroiwa, A., Yamashita, Y., Inui, M., Yuasa, T., Ono, M., Nagabukuro, A., et al. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. The Journal of Biological Chemistry 273:2 (1998), 1070–1074.
120. Kursar, M., Koch, M., Mittrücker, H.-W., Nouailles, G., Bonhagen, K., Kamradt, T., et al. Cutting edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. Journal of Immunology 178:5 (2007), 2661–2665 http://doi.org/10.4049/jimmunol.178.5.2661.
121. Kuswanto, W., Burzyn, D., Panduro, M., Wang, K.K., Jang, Y.C., Wagers, A.J., et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin-33-dependent accumulation of regulatory T cells. Immunity 44:2 (2016), 355–367 http://doi.org/10.1016/j.immuni.2016.01.009.
122. Ladoire, S., Martin, F., Ghiringhelli, F., Prognostic role of FOXP3 + regulatory T cells infiltrating human carcinomas: The paradox of colorectal cancer. Cancer Immunology, Immunotherapy 60:7 (2011), 909–918 http://doi.org/10.1007/s00262-011-1046-y.
123. Lafaille, J.J., Nagashima, K., Katsuki, M., Tonegawa, S., High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78:3 (1994), 399–408 http://doi.org/10.1016/0092-8674(94)90419-7.
124. Lahl, K., Mayer, C.T., Bopp, T., Huehn, J., Loddenkemper, C., Eberl, G., et al. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. Journal of Immunology (Baltimore, Md.: 1950) 183:9 (2009), 5662–5672 http://doi.org/10.4049/jimmunol.0803762.
125. Li, Q., Guo, Z., Xu, X., Xia, S., Cao, X., Pulmonary stromal cells induce the generation of regulatory DC attenuating T-cell-mediated lung inflammation. European Journal of Immunology 38:10 (2008), 2751–2761 http://doi.org/10.1002/eji.200838542.
126. Li, X., Kostareli, E., Suffner, J., Garbi, N., Hämmerling, G.J., Efficient Treg depletion induces T-cell infiltration and rejection of large tumors. European Journal of Immunology 40:12 (2010), 3325–3335 http://doi.org/10.1002/eji.201041093.
127. Li, M.O., Wan, Y.Y., Flavell, R.A., T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:5 (2007), 579–591 http://doi.org/10.1016/j.immuni.2007.03.014.
128. Liang, B., Workman, C., Lee, J., Chew, C., Dale, B.M., Colonna, L., et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. Journal of Immunology 180:9 (2008), 5916–5926 http://doi.org/10.4049/jimmunol.180.9.5916.
129. Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine 15:2 (2009), 192–199 http://doi.org/10.1038/nm.1927.
130. Lin, J., Yang, L., Silva, H.M., Trzeciak, A., Choi, Y., Schwab, S.R., et al. Increased generation of Foxp3 + regulatory T cells by manipulating antigen presentation in the thymus. Nature Communications, 7, 2016, 10562 http://doi.org/10.1038/ncomms10562.
131. Liyanage, U.K., Moore, T.T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Journal of Immunology 169:5 (2002), 2756–2761 http://doi.org/10.4049/jimmunol.169.5.2756.
132. Lloyd, C.M., Hawrylowicz, C.M., Regulatory T cells in asthma. Immunity 31:3 (2009), 438–449 http://doi.org/10.1016/j.immuni.2009.08.007.
133. Lohoff, M., Mittrücker, H.W., Prechtl, S., Bischof, S., Sommer, F., Kock, S., et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proceedings of the National Academy of Sciences of the United States of America 99:18 (2002), 11808–11812.
134. Loser, K., Apelt, J., Voskort, M., Mohaupt, M., Balkow, S., Schwarz, T., et al. IL-10 controls ultraviolet-induced carcinogenesis in mice. Journal of Immunology 179:1 (2007), 365–371 http://doi.org/10.4049/jimmunol.179.1.365.
135. Lu-Kuo, J.M., Joyal, D.M., Austen, K.F., Katz, H.R., gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. The Journal of Biological Chemistry 274:9 (1999), 5791–5796 http://doi.org/10.1074/jbc.274.9.5791.
136. Maloy, K.J., Salaun, L., Cahill, R., Dougan, G., Saunders, N.J., Powrie, F., CD4+CD25 + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. The Journal of Experimental Medicine 197:1 (2003), 111–119.
137. Mann, M.K., Maresz, K., Shriver, L.P., Tan, Y., Dittel, B.N., B cell regulation of CD4+CD25 + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. Journal of Immunology 178:6 (2007), 3447–3456 http://doi.org/10.4049/jimmunol.178.6.3447.
138. Mclachlan, J.B., Catron, D.M., Moon, J.J., Jenkins, M.K., Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin. Immunity 30:2 (2009), 277–288 http://doi.org/10.1016/j.immuni.2008.11.013.
139. Mellor, A.L., Munn, D.H., Ido expression by dendritic cells: Tolerance and tryptophan catabolism. Nature Reviews. Immunology 4:10 (2004), 762–774 http://doi.org/10.1038/nri1457.
140. Mercer, F., Kozhaya, L., Unutmaz, D., Expression and function of TNF and IL-1 receptors on human regulatory T cells. PLoS One, 5(1), 2010, e8639 http://doi.org/10.1371/journal.pone.0008639.
141. Miller, J.F.A.P., Immunological function of the thymus. Lancet 278:7205 (1961), 748–749 http://doi.org/10.1016/S0140-6736(61)90693-6.
142. Miller, J.F.A.P., Immunological significance of the thymus of the adult mouse. Nature 195:4848 (1962), 1318–1319 http://doi.org/10.1038/1951318a0.
143. Miller, J.F.A.P., The discovery of thymus function and of thymus-derived lymphocytes. Immunological Reviews 185:1 (2002), 7–14 http://doi.org/10.1034/j.1600-065X.2002.18502.x.
144. Miller, J.F., Mitchell, G.F., Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocyte. Journal of Experimental Medicine 128:4 (1968), 801–820.
145. Milpied, P., Renand, A., Bruneau, J., Mendes-da-Cruz, D.A., Jacquelin, S., Asnafi, V., et al. Neuropilin-1 is not a marker of human Foxp3 + Treg. European Journal of Immunology 39:6 (2009), 1466–1471 http://doi.org/10.1002/eji.200839040.
146. Mounier, R., Théret, M., Arnold, L., Cuvellier, S., Bultot, L., Göransson, O., et al. AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metabolism 18:2 (2013), 251–264 http://doi.org/10.1016/j.cmet.2013.06.017.
147. Nakamura, K., Kitani, A., Strober, W., Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. The Journal of Experimental Medicine 194:5 (2001), 629–644.
148. Nirschl, C.J., Drake, C.G., Molecular pathways: Coexpression of immune checkpoint molecules: Signaling pathways and implications for cancer immunotherapy. Clinical Cancer Research 19:18 (2013), 4917–4924 http://doi.org/10.1158/1078-0432.CCR-12-1972.
149. Nishizuka, Y., Sakakura, T., Thymus and reproduction: Sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:3906 (1969), 753–755.
150. Oberle, N., Eberhardt, N., Falk, C.S., Krammer, P.H., Suri-Payer, E., Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3 + regulatory T cells: Independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. Journal of Immunology 179:6 (2007), 3578–3587 http://doi.org/10.4049/jimmunol.179.6.3578.
151. Ohnmacht, C., Park, J.-H., Cording, S., Wing, J.B., Atarashi, K., Obata, Y., et al. The microbiota regulates type 2 immunity through RORγt + T cells. Science 349 (2015), 989–993 aac4263 http://doi.org/10.1126/science.aac4263.
152. Olivares-Villagómez, D., Wang, Y., Lafaille, J.J., Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. Journal of Experimental Medicine 188:10 (1998), 1883–1894 http://doi.org/10.1084/jem.188.10.1883.
153. Onishi, Y., Fehervari, Z., Yamaguchi, T., Sakaguchi, S., Foxp3 + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proceedings of the National Academy of Sciences of the United States of America 105:29 (2008), 10113–10118 http://doi.org/10.1073/pnas.0711106105.
154. Pabbisetty, S.K., Rabacal, W., Maseda, D., Cendron, D., Collins, P.L., Hoek, K.L., et al. KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production. Proceedings of the National Academy of Sciences of the United States of America 111:26 (2014), 9579–9584 http://doi.org/10.1073/pnas.1323493111.
155. Pandiyan, P., Zheng, L., Ishihara, S., Reed, J., Lenardo, M.J., CD4+CD25+Foxp3 + regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4 + T cells. Nature Immunology 8:12 (2007), 1353–1362 http://doi.org/10.1038/ni1536.
156. Park, S.-G., Mathur, R., Long, M., Hosh, N., Hao, L., Hayden, M.S., et al. T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells. Immunity 33:5 (2010), 791–803 http://doi.org/10.1016/j.immuni.2010.10.014.
157. Pastorelli, L., Garg, R.R., Hoang, S.B., Spina, L., Mattioli, B., Scarpa, M., et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences of the United States of America 107:17 (2010), 8017–8022 http://doi.org/10.1073/pnas.0912678107.
158. Pereira, S.S., Alvarez-Leite, J.I., Low-grade inflammation, obesity, and diabetes. Current Obesity Reports 3:4 (2014), 422–431 http://doi.org/10.1007/s13679-014-0124-9.
159. Perry, J.S.A., Hsieh, C.-S., Development of T-cell tolerance utilizes both cell-autonomous and cooperative presentation of self-antigen. Immunological Reviews 271:1 (2016), 141–155 http://doi.org/10.1111/imr.12403.
160. Peters, J.H., Koenen, H.J.P.M., Fasse, E., Tijssen, H.J., IJzermans, J.N.M., Groenen, P.J.T.A., et al. Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells. Blood 122:13 (2013), 2213–2223 http://doi.org/10.1182/blood-2013-03-489443.
161. Piccirillo, C.A., Letterio, J.J., Thornton, A.M., McHugh, R.S., Mamura, M., Mizuhara, H., et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. The Journal of Experimental Medicine 196:2 (2002), 237–246.
162. Pichery, M., Mirey, E., Mercier, P., Lefrancais, E., Dujardin, A., Ortega, N., et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: In situ analysis using a novel Il-33-LacZ gene trap reporter strain. Journal of Immunology (Baltimore, Md.: 1950) 188:7 (2012), 3488–3495 http://doi.org/10.4049/jimmunol.1101977.
163. Proietto, A.I., van Dommelen, S., Zhou, P., Rizzitelli, A., D'Amico, A., Steptoe, R.J., et al. Dendritic cells in the thymus contribute to T-regulatory cell induction. Proceedings of the National Academy of Sciences of the United States of America 105:50 (2008), 19869–19874 http://doi.org/10.1073/pnas.0810268105.
164. Puccetti, P., Grohmann, U., IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-kB activation. Nature Reviews. Immunology 7:10 (2007), 817–823 http://doi.org/10.1038/nri2163.
165. Qureshi, O.S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E.M., et al. Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4. Science 332:6029 (2011), 600–603 http://doi.org/10.1126/science.1202947.
166. Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Francisco, L., et al. Blockade of CTLA-4 on CD4+CD25 + regulatory T cells abrogates their function in vivo. Journal of Immunology 177:7 (2006), 4376–4383 http://doi.org/10.4049/jimmunol.177.7.4376.
167. Read, S., Malmstrom, V., Powrie, F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. Journal of Experimental Medicine 192:2 (2000), 295–302.
168. Ren, X., Ye, F., Jiang, Z., Chu, Y., Xiong, S., Wang, Y., Involvement of cellular death in TRAIL|[sol]|DR5-dependent suppression induced by CD4|[plus]|CD25|[plus]| regulatory T cells. Cell Death and Differentiation 14:12 (2007), 2076–2084 http://doi.org/10.1038/sj.cdd.4402220.
169. Rengarajan, J., Mowen, K.A., McBride, K.D., Smith, E.D., Singh, H., Glimcher, L.H., Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. Journal of Experimental Medicine 195:8 (2002), 1003–1012.
170. Rodriguez, R.S., Pauli, M.L., Neuhaus, I.M., Yu, S.S., Arron, S.T., Harris, H.W., et al. Memory regulatory T cells reside in human skin. The Journal of Clinical Investigation 124:3 (2014), 1027–1036 http://doi.org/10.1172/JCI72932.
171. Round, J.L., Mazmanian, S.K., Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America 107:27 (2010), 12204–12209 http://doi.org/10.1073/pnas.0909122107.
172. Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:4 (2008), 546–558 http://doi.org/10.1016/j.immuni.2008.02.017.
173. Ruffell, D., Mourkioti, F., Gambardella, A., Kirstetter, P., Lopez, R.G., Rosenthal, N., et al. A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proceedings of the National Academy of Sciences of the United States of America 106:41 (2009), 17475–17480 http://doi.org/10.1073/pnas.0908641106.
174. Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., et al. Tumor-infiltrating FOXP3 + T regulatory cells show strong prognostic significance in colorectal cancer. Journal of Clinical Oncology 27:2 (2009), 186–192 http://doi.org/10.1200/JCO.2008.18.7229.
175. Sallusto, F., Mackay, C.R., Lanzavecchia, A., The role of chemokine receptors in primary, effector, and memory immune responses. Annual Review of Immunology 18 (2000), 593–620 http://doi.org/10.1146/annurev.immunol.18.1.593.
176. Salomon, B., Bluestone, J.A., Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annual Review of Immunology 19:1 (2001), 225–252 http://doi.org/10.1146/annurev.immunol.19.1.225.
177. Santegoets, S.J.A.M., Dijkgraaf, E.M., Battaglia, A., Beckhove, P., Britten, C.M., Gallimore, A., et al. Monitoring regulatory T cells in clinical samples: Consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. Cancer Immunology, Immunotherapy 64:10 (2015), 1271–1286 http://doi.org/10.1007/s00262-015-1729-x.
178. Sarris, M., Andersen, K.G., Randow, F., Mayr, L., Betz, A.G., Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28:3 (2008), 402–413 http://doi.org/10.1016/j.immuni.2008.01.012.
179. Sather, B.D., Treuting, P., Perdue, N., Miazgowicz, M., Fontenot, J.D., Rudensky, A.Y., et al. Altering the distribution of Foxp3 + regulatory T cells results in tissue-specific inflammatory disease. Journal of Experimental Medicine 204:6 (2007), 1335–1347 http://doi.org/10.1084/jem.20070081.
180. Scharschmidt, T.C., Vasquez, K.S., Truong, H.-A., Gearty, S.V., Pauli, M.L., Nosbaum, A., et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 43:5 (2015), 1011–1021 http://doi.org/10.1016/j.immuni.2015.10.016.
181. Scheffold, A., Murphy, K.M., Höfer, T., Competition for cytokines: Treg cells take all. Nature Immunology 8:12 (2007), 1285–1287 http://doi.org/10.1038/ni1207-1285.
182. Schenkel, J.M., Masopust, D., Tissue-resident memory T cells. Immunity 41:6 (2014), 886–897 http://doi.org/10.1016/j.immuni.2014.12.007.
183. Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E.A., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513:7519 (2014), 564–568 http://doi.org/10.1038/nature13577.
184. Schuler, P.J., Schilling, B., Harasymczuk, M., Hoffmann, T.K., Johnson, J., Lang, S., et al. Phenotypic and functional characteristics of CD4 + CD39 + FOXP3 + and CD4 + CD39 + FOXP3neg T-cell subsets in cancer patients. European Journal of Immunology 42:7 (2012), 1876–1885 http://doi.org/10.1002/eji.201142347.
185. Seddiki, N., Santner-Nanan, B., Tangye, S.G., Alexander, S.I., Solomon, M., Lee, S., et al. Persistence of naive CD45RA + regulatory T cells in adult life. Blood 107:7 (2006), 2830–2838 http://doi.org/10.1182/blood-2005-06-2403.
186. Seddon, B., Mason, D., The third function of the thymus. Immunology Today 21:2 (2000), 95–99.
187. + regulatory T cells. Science 349:6251 (2015), 993–997 http://doi.org/10.1126/science.aaa9420.
188. Seneschal, J., Clark, R.A., Gehad, A., Baecher-Allan, C.M., Kupper, T.S., Human epidermal langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:5 (2012), 873–884 http://doi.org/10.1016/j.immuni.2012.03.018.
189. Shen, S., Ding, Y., Tadokoro, C.E., Olivares-Villagómez, D., Camps-Ramírez, M., de Lafaille, M.A.C., et al. Control of homeostatic proliferation by regulatory T cells. The Journal of Clinical Investigation 115:12 (2005), 3517–3526 http://doi.org/10.1172/JCI25463.
190. Shinoda, K., Tokoyoda, K., Hanazawa, A., Hayashizaki, K., Zehentmeier, S., Hosokawa, H., et al. Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proceedings of the National Academy of Sciences of the United States of America 109:19 (2012), 7409–7414 http://doi.org/10.1073/pnas.1118539109.
191. Shiow, L.R., Rosen, D.B., Brdičková, N., et al. CD69 acts downstream of interferon-|[alpha]|/|[beta]| to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440:7083 (2006), 540–544 http://doi.org/10.1038/nature04606.
192. Singh, K., Hjort, M., Thorvaldson, L., Sandler, S., Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice. Scientific Reports, 5, 2015, 7767 http://doi.org/10.1038/srep07767.
193. Skon, C.N., Lee, J.-Y., Anderson, K.G., Masopust, D., Hogquist, K.A., Jameson, S.C., Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8 + T cells. Nature Immunology 14:12 (2013), 1285–1293 http://doi.org/10.1038/ni.2745.
194. Soroosh, P., Doherty, T.A., Duan, W., Mehta, A.K., Choi, H., Adams, Y.F., et al. Lung-resident tissue macrophages generate Foxp3 + regulatory T cells and promote airway tolerance. The Journal of Experimental Medicine 210:4 (2013), 775–788 http://doi.org/10.1084/jem.20121849.
195. Stassen, M., Fondel, S., Bopp, T., Richter, C., Müller, C., Kubach, J., et al. Human CD25 + regulatory T cells: Two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4 + T helper cells. European Journal of Immunology 34:5 (2004), 1303–1311 http://doi.org/10.1002/eji.200324656.
196. Steer, T., Carpenter, H., Tuohy, K., Gibson, G.R., Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutrition Research Reviews 13:02 (2000), 229–254 http://doi.org/10.1079/095442200108729089.
197. Stefka, A.T., Feehley, T., Tripathi, P., Qiu, J., McCoy, K., Mazmanian, S.K., et al. Commensal bacteria protect against food allergen sensitization. Proceedings of the National Academy of Sciences of the United States of America 111:36 (2014), 13145–13150 http://doi.org/10.1073/pnas.1412008111.
198. Suffia, I.J., Reckling, S.K., Piccirillo, C.A., Goldszmid, R.S., Belkaid, Y., Infected site-restricted Foxp3 + natural regulatory T cells are specific for microbial antigens. Journal of Experimental Medicine 203:3 (2006), 777–788 http://doi.org/10.1084/jem.20052056.
199. Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:6 (2000), 655–669.
200. Tadokoro, C.E., Shakhar, G., Shen, S., Ding, Y., Lino, A.C., Maraver, A., et al. Regulatory T cells inhibit stable contacts between CD4 + T cells and dendritic cells in vivo. The Journal of Experimental Medicine 203:3 (2006), 505–511.
201. Taguchi, O., Nishizuka, Y., Experimental autoimmune orchitis after neonatal thymectomy in the mouse. Clinical and Experimental Immunology 46:2 (1981), 425–434.
202. Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., et al. Immunologic self-tolerance maintained by CD25+CD4 + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. International Immunology 10:12 (1998), 1969–1980.
203. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. The Journal of Experimental Medicine 192:2 (2000), 303–310.
204. Tang, Q., Adams, J.Y., Tooley, A.J., Bi, M., Fife, B.T., Serra, P., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunology 7:1 (2006), 83–92.
205. Tang, Q., Bluestone, J.A., The Foxp3 + regulatory T cell: A jack of all trades, master of regulation. Nature Reviews. Immunology 9:3 (2008), 239–244.
206. Tanoue, T., Atarashi, K., Honda, K., Development and maintenance of intestinal regulatory T cells. Nature Reviews. Immunology 16:5 (2016), 295–309 http://doi.org/10.1038/nri.2016.36.
207. Thiault, N., Darrigues, J., Adoue, V., Gros, M., Binet, B., Perals, C., et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nature Immunology 16:6 (2015), 628–634 http://doi.org/10.1038/ni.3150.
208. Thome, J.J.C., Farber, D.L., Emerging concepts in tissue-resident T cells: Lessons from humans. Trends in Immunology 36:7 (2015), 428–435 http://doi.org/10.1016/j.it.2015.05.003.
209. Thornton, A.M., Shevach, E.M., CD4+CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. Journal of Experimental Medicine 188:2 (1998), 287–296.
210. Tran, D.Q., Andersson, J., Hardwick, D., Bebris, L., Illei, G.G., Shevach, E.M., Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3 + regulatory T cells allows for their purification from expansion cultures. Blood 113:21 (2009), 5125–5133 http://doi.org/10.1182/blood-2009-01-199950.
211. Ulges, A., Klein, M., Reuter, S., Gerlitzki, B., Hoffmann, M., Grebe, N., et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nature Immunology 16:3 (2015), 267–275 http://doi.org/10.1038/ni.3083.
212. Vaeth, M., Gogishvili, T., Bopp, T., Klein, M., Berberich-Siebelt, F., Gattenloehner, S., et al. Regulatory T cells facilitate the nuclear accumulation of inducible cAMP early repressor (ICER) and suppress nuclear factor of activated T cell c1 (NFATc1). Proceedings of the National Academy of Sciences of the United States of America 108:6 (2011), 2480–2485 http://doi.org/10.1073/pnas.1009463108.
213. Vahl, J.C., Drees, C., Heger, K., Heink, S., Fischer, J.C., Nedjic, J., et al. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 41:5 (2014), 722–736 http://doi.org/10.1016/j.immuni.2014.10.012.
214. Valmori, D., Merlo, A., Souleimanian, N.E., Hesdorffer, C.S., Ayyoub, M., A peripheral circulating compartment of natural naive CD4 Tregs. The Journal of Clinical Investigation 115:7 (2005), 1953–1962 http://doi.org/10.1172/JCI23963.
215. Vasanthakumar, A., Moro, K., Xin, A., Liao, Y., Gloury, R., Kawamoto, S., et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nature Immunology 16 (2015), 276–285 http://doi.org/10.1038/ni.3085.
216. Vignali, D.A.A., Collison, L.W., Workman, C.J., How regulatory T cells work. Nature Reviews. Immunology 8:7 (2008), 523–532 http://doi.org/10.1038/nri2343.
217. Villalta, S.A., Rosenthal, W., Martinez, L., Kaur, A., Sparwasser, T., Tidball, J.G., et al. Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy. Science Translational Medicine, 6(258), 2014, 258ra142 http://doi.org/10.1126/scitranslmed.3009925.
218. von Boehmer, H., Developmental biology of T cells in T cell-receptor transgenic mice. Annual Review of Immunology 8:1 (1990), 531–556 http://doi.org/10.1146/annurev.iy.08.040190.002531.
219. Vukmanovic-Stejic, M., Agius, E., Booth, N., Dunne, P.J., Lacy, K.E., Reed, J.R., et al. The kinetics of CD4+Foxp3 + T cell accumulation during a human cutaneous antigen-specific memory response in vivo. The Journal of Clinical Investigation 118:11 (2008), 3639–3650 http://doi.org/10.1172/JCI35834.
220. Wang, L., Liu, R., Li, W., Chen, C., Katoh, H., Chen, G.-Y., et al. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 16:4 (2009), 336–346 http://doi.org/10.1016/j.ccr.2009.08.016.
221. Weiss, J.M., Bilate, A.M., Gobert, M., Ding, Y., Curotto de Lafaille, M.A., Parkhurst, C.N., et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3 + T reg cells. The Journal of Experimental Medicine 209:10 (2012), 1723–1742 S1 http://doi.org/10.1084/jem.20120914.
222. Weist, B.M., Kurd, N., Boussier, J., Chan, S.W., Robey, E.A., Thymic regulatory T cell niche size is dictated by limiting IL-2 from antigen-bearing dendritic cells and feedback competition. Nature Immunology 16:6 (2015), 635–641 http://doi.org/10.1038/ni.3171.
223. Whiteside, T.L., Induced regulatory T cells in inhibitory microenvironments created by cancer. Expert Opinion on Biological Therapy 14:10 (2014), 1411–1425 http://doi.org/10.1517/14712598.2014.927432.
224. Wieczorek, G., Asemissen, A., Model, F., Turbachova, I., Floess, S., Liebenberg, V., et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Research 69:2 (2009), 599–608 http://doi.org/10.1158/0008-5472.CAN-08-2361.
225. Williams, J.W., Tjota, M.Y., Clay, B.S., Vander Lugt, B., Bandukwala, H.S., Hrusch, C.L., et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nature Communications, 4, 2013, 2990 http://doi.org/10.1038/ncomms3990.
226. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., et al. CTLA-4 control over Foxp3 + regulatory T cell function. Science 322:5899 (2008), 271–275 http://doi.org/10.1126/science.1160062.
227. Wohlfert, E.A., Grainger, J.R., Bouladoux, N., Konkel, J.E., Oldenhove, G., Ribeiro, C.H., et al. GATA3 controls Foxp3 + regulatory T cell fate during inflammation in mice. The Journal of Clinical Investigation 121:11 (2011), 4503–4515 http://doi.org/10.1172/JCI57456.
228. Wolf, D., Wolf, A.M., Rumpold, H., Fiegl, H., Zeimet, A.G., Muller-Holzner, E., et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clinical Cancer Research 11:23 (2005), 8326–8331.
229. Woo, E.Y., Chu, C.S., Goletz, T.J., Schlienger, K., Yeh, H., Coukos, G., et al. Regulatory CD4+CD25 + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Research 61:12 (2001), 4766–4772 http://doi.org/10.1016/0167-5699(96)10027-X.
230. Woo, S.-R., Turnis, M.E., Goldberg, M.V., Bankoti, J., Selby, M., Nirschl, C.J., et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T cell function to promote tumoral immune escape. Cancer Research 72:4 (2012), 917–927 http://doi.org/10.1158/0008-5472.CAN-11-1620.
231. Yadav, M., Louvet, C., Davini, D., Gardner, J.M., Martinez-Llordella, M., Bailey-Bucktrout, S., et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. The Journal of Experimental Medicine 209 (2012), 1713–1722 http://doi.org/10.1084/jem.20120822.
232. Yan, J., Zhang, Y., Zhang, J.-P., Liang, J., Li, L., Zheng, L., Tim-3 expression defines regulatory T cells in human tumors. PLoS One, 8(3), 2013, e58006 http://doi.org/10.1371/journal.pone.0058006.
233. Yang, B.-H., Hagemann, S., Mamareli, P., Lauer, U., Hoffmann, U., Beckstette, M., et al. Foxp3 + T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunology 9:2 (2015), 444–457 http://doi.org/10.1038/mi.2015.74.
234. Yu, X., Harden, K., Gonzalez, L.C., Francesco, M., Chiang, E., Irving, B., et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nature Immunology 10:1 (2009), 48–57 http://doi.org/10.1038/ni.1674.
235. Zarek, P.E., Huang, C.-T., Lutz, E.R., Kowalski, J., Horton, M.R., Linden, J., et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111:1 (2008), 251–259 http://doi.org/10.1182/blood-2007-03-081646.
236. Zeyda, M., Wernly, B., Demyanets, S., Kaun, C., Hämmerle, M., Hantusch, B., et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. International Journal of Obesity (2005) 37:5 (2013), 658–665 http://doi.org/10.1038/ijo.2012.118.
237. Zhao, D.M., Thornton, A.M., Dipaolo, R.J., Shevach, E.M., Activated CD4+CD25 + T cells selectively kill B lymphocytes. Blood 107 (2006), 3925–3932.
238. Zheng, Y., Chaudhry, A., Kas, A., deRoos, P., Kim, J.M., Chu, T.-T., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458:7236 (2009), 351–356 http://doi.org/10.1038/nature07674.
239. Zhu, J., Yamane, H., Paul, W.E., Differentiation of effector CD4 T cell populations (*). Annual Review of Immunology 28:1 (2010), 445–489 http://doi.org/10.1146/annurev-immunol-030409-101212.
240. Ziegler, S.F., FOXP3: Of mice and men. Annual Review of Immunology 24:1 (2006), 209–226 http://doi.org/10.1146/annurev.immunol.24.021605.090547.
241. Zuo, T., Wang, L., Morrison, C., Chang, X., Zhang, H., Li, W., et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 129:7 (2007), 1275–1286 http://doi.org/10.1016/j.cell.2007.04.034.